CD33 drives cutaneous melanoma: mendelian randomization confirms causality, multi-omics and in vitro experiments reveal M2 macrophage polarization-mediated progression.

BACKGROUND: Cutaneous melanoma (CM), one of the most prevalent types of melanomas globally, continues to increase in incidence and mortality. Despite significant advances in targeted and immune therapies, most patients fail to achieve durable respons…

Preview only. Read the full abstract at the source